# Miikana

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/miikana

- Industry: Pharmaceuticals
- Headquarters: Rockville, US
- Total disclosed funding: $8.3M
- Latest round: Series B (Jun 30, 2005)
- Investors on record: 4

## About

Founded in 2002, Miikana Therapeutics is a clinically driven biopharmaceutical company discovering and developing targeted medicines for the treatment of cancer.

## Funding rounds

- Series B, Jun 30, 2005, $1M — Aravis, Novartis Venture Fund, 5AM Ventures, Queensland Asset Management
- Series A, Oct 6, 2004, $3M — Aravis, Novartis Venture Fund, 5AM Ventures, Queensland Asset Management
- Series A, Oct 1, 2003, $4.3M — Aravis, Novartis Venture Fund, 5AM Ventures, Queensland Asset Management

## Investors

- Aravis (https://capitalatlas.ai/funds/aravis) — Series A, Series B
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A, Series B
- Queensland Asset Management — Series A, Series B